In preclinical models of lung cancer, induced expression of lysyl hydroxylases 2 (LH2) in CAFs induced a collagen cross-link switch in the tumor stroma, which in turn promoted the migratory and invasive properties of lung adenocarcinoma [181]. The gene discussed is PLOD2; the disease is lung adenocarcinoma.